| 摘要 |
HIV PROTEASE INHIBITORS, OBTAINABLE BY CHEMICAL SYNTHESIS, INHIBIT OR BLOCK THE BIOLOGICAL ACTIVITY OF THE HIV PROTEASE ENZYME, CAUSING THE REPLICATION OF THE HIV VIRUS TO TERMINATE. THESE COMPOUNDS, AS WELL AS PHARMACEUTICAL COMPOSITION THAT CONTAIN THESE COMPOUNDS AND OPTIONALLY OTHER ANTI-VIRAL AGENTS AS ACTIVE INGREADIENTS, ARE SUITABLE FOR TREATING PATIENTS OR HOSTS INFECTED WITH THE HIV VIRUS, WHICH IS KNOWN TO CAUSE AIDS.
|
| 申请人 |
AGOURON PHARMACEUTICALS, INC. |
发明人 |
DRESSMAN, BRUCE A.;SHEPHERD, TIMOTHY A.;RODRIGUEZ, MICHAEL J.;FRITZ, JAMES E.;HAMMOND, MARLYS.;HORNBACK, WILLIAM J.;KALDOR, STEPHEN W.;KALISH, VINCENT J.;MUNROE, JOHN E.;REICH, SIEGFRIED HEINZ.;TATLOCK, JOHN H. |
